The novel approach of the medication represents a significant development in the handling of diabetes mellitus type 2. Unlike existing medications, tirzepatide affects two pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide522893.blogdomago.com/40529830/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment